Salesforce
CRM
Coinbase
COIN
Oracle
ORCL
4
Tesla
TSLA
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
QNRX Quoin Pharmaceuticals
- 6.633
- +0.073+1.11%
Close Apr 24 16:00 ET
- 6.633
- 0.0000.00%
Post 20:01 ET
3.90MMarket Cap-0.10P/E (TTM)
6.871High6.338Low16.27KVolume6.720Open6.560Pre Close109.11KTurnover2.98%Turnover RatioLossP/E (Static)588.17KShares54.95052wk High0.42P/B3.63MFloat Cap5.01052wk Low--Dividend TTM546.54KShs Float1417500.000Historical High--Div YieldTTM8.13%Amplitude5.010Historical Low6.707Avg Price1Lot Size
Quoin Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 0.09%-7.86M | 30.62%-2.24M | -64.91%-2.18M | -27.62%-2.01M | 17.87%-1.43M | 7.27%-7.86M | -65.97%-3.22M | 42.38%-1.32M | 26.90%-1.57M | 16.58%-1.75M |
| Net income from continuing operations | -3.18%-8.96M | -12.75%-2.31M | -21.97%-2.35M | 6.31%-1.97M | 10.59%-2.33M | 7.41%-8.69M | -2.44%-2.05M | 36.40%-1.93M | 21.03%-2.11M | -54.69%-2.6M |
| Depreciation and amortization | -3.57%100K | -2.63%25K | -3.88%25K | -3.89%25K | -3.89%25K | -0.32%103.71K | -1.30%25.67K | -0.00%26.01K | 0.00%26.01K | 0.00%26.01K |
| Change In working capital | -102.24%-2.14K | 84.87%-211.5K | -122.71%-102.05K | -201.83%-347.2K | -6.27%658.61K | 201.16%95.45K | -200.78%-1.4M | 273.37%449.35K | 30.47%340.97K | 90.87%702.67K |
| -Change in prepaid assets | -769.73%-278.09K | -49.32%-595.2K | 138.81%376.77K | -146.02%-75.79K | -86.29%16.13K | -66.37%41.52K | -0.83%-398.6K | -52.21%157.77K | 1,049.88%164.68K | -42.88%117.68K |
| -Change in payables and accrued expense | 411.75%275.96K | 138.41%383.7K | -264.21%-478.81K | -253.95%-271.41K | 9.83%642.48K | 124.76%53.92K | -1,341.21%-998.95K | 149.48%291.59K | -36.74%176.29K | 260.81%584.99K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 0.09%-7.86M | 30.62%-2.24M | -64.91%-2.18M | -27.62%-2.01M | 17.87%-1.43M | 7.27%-7.86M | -65.97%-3.22M | 42.38%-1.32M | 26.90%-1.57M | 16.58%-1.75M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -186.29%-1.89M | -220.21%-3.18M | 316,685.75%2.6M | 3.95%3.16M | -27.90%-4.47M | 121.56%2.19M | 2.64M | 100.01%821 | 1,617.50%3.04M | -6,883.01%-3.49M |
| Net investment purchase and sale | -186.29%-1.89M | -220.21%-3.18M | 316,685.75%2.6M | 3.95%3.16M | -27.90%-4.47M | 122.11%2.19M | --2.64M | 100.01%821 | --3.04M | ---3.49M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -186.29%-1.89M | -220.21%-3.18M | 316,685.75%2.6M | 3.95%3.16M | -27.90%-4.47M | 121.56%2.19M | --2.64M | 100.01%821 | 1,617.50%3.04M | -6,883.01%-3.49M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 110.24%10.97M | 3,343.14%5.92M | 45.49%-149.89K | -81.70%-136.28K | -7.25%5.33M | -62.76%5.22M | 59.14%-182.58K | -101.86%-275K | 50.00%-75K | 3,932.84%5.75M |
| Net other financing activities | 110.24%10.97M | 3,343.14%5.92M | 45.49%-149.89K | -81.70%-136.28K | -7.25%5.33M | -63.57%5.22M | -35.05%-182.58K | -101.86%-275K | 50.00%-75K | 3,932.84%5.75M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 110.24%10.97M | 3,343.14%5.92M | 45.49%-149.89K | -81.70%-136.28K | -7.25%5.33M | -62.76%5.22M | 59.14%-182.58K | -101.86%-275K | 50.00%-75K | 3,932.84%5.75M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.06%2.4M | -1.48%3.12M | -40.22%2.85M | -45.62%1.83M | -16.06%2.4M | -61.77%2.86M | -39.74%3.16M | 77.06%4.76M | -35.02%3.37M | -61.77%2.86M |
| Current changes in cash | 366.01%1.22M | 166.46%506.59K | 117.02%271.62K | -27.08%1.01M | -211.04%-567.67K | 90.06%-459.43K | 68.10%-762.23K | -162.28%-1.6M | 155.46%1.39M | 122.29%511.23K |
| End cash Position | 50.90%3.62M | 50.90%3.62M | -1.48%3.12M | -40.22%2.85M | -45.62%1.83M | -16.06%2.4M | -16.06%2.4M | -39.74%3.16M | 77.06%4.76M | -35.02%3.37M |
| Free cash flow | 0.09%-7.86M | 30.62%-2.24M | -64.91%-2.18M | -27.62%-2.01M | 17.87%-1.43M | 9.92%-7.86M | -65.97%-3.22M | 42.38%-1.32M | 33.11%-1.57M | 18.52%-1.75M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025